Insufficient scRNA-seq data for expression of DEFA1 at single-cell level.
Insufficient scRNA-seq data for expression of DEFA1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
peripheral blood | 45% | 253.02 | 420 / 929 | 0% | 0 | 0 / 0 |
spleen | 19% | 16.20 | 45 / 241 | 0% | 0 | 0 / 0 |
lung | 6% | 1.21 | 34 / 578 | 0% | 0.00 | 4 / 1155 |
stomach | 0% | 0 | 0 / 359 | 0% | 0.00 | 1 / 286 |
prostate | 0% | 0 | 0 / 245 | 0% | 0.00 | 1 / 502 |
intestine | 0% | 0 | 0 / 966 | 0% | 0.00 | 1 / 527 |
adipose | 0% | 0.01 | 2 / 1204 | 0% | 0 | 0 / 0 |
thymus | 0% | 0 | 0 / 653 | 0% | 0.00 | 1 / 605 |
brain | 0% | 0 | 0 / 2642 | 0% | 0.00 | 1 / 705 |
heart | 0% | 0.02 | 1 / 861 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 0% | 0.00 | 1 / 901 |
breast | 0% | 0 | 0 / 459 | 0% | 0.00 | 1 / 1118 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0 | 0 / 258 | 0% | 0 | 0 / 230 |
bladder | 0% | 0 | 0 / 21 | 0% | 0 | 0 / 504 |
blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
esophagus | 0% | 0 | 0 / 1445 | 0% | 0 | 0 / 183 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 0% | 0 | 0 / 406 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ovary | 0% | 0 | 0 / 180 | 0% | 0 | 0 / 430 |
pancreas | 0% | 0 | 0 / 328 | 0% | 0 | 0 / 178 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
skin | 0% | 0 | 0 / 1809 | 0% | 0 | 0 / 472 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
uterus | 0% | 0 | 0 / 170 | 0% | 0 | 0 / 459 |
GO_0050832 | Biological process | defense response to fungus |
GO_0019731 | Biological process | antibacterial humoral response |
GO_0042832 | Biological process | defense response to protozoan |
GO_0050829 | Biological process | defense response to Gram-negative bacterium |
GO_0051607 | Biological process | defense response to virus |
GO_0006935 | Biological process | chemotaxis |
GO_0051673 | Biological process | disruption of plasma membrane integrity in another organism |
GO_0006955 | Biological process | immune response |
GO_0031640 | Biological process | killing of cells of another organism |
GO_0050830 | Biological process | defense response to Gram-positive bacterium |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0061844 | Biological process | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO_0002227 | Biological process | innate immune response in mucosa |
GO_0010818 | Biological process | T cell chemotaxis |
GO_0051873 | Biological process | killing by host of symbiont cells |
GO_0030520 | Biological process | estrogen receptor signaling pathway |
GO_0035578 | Cellular component | azurophil granule lumen |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005796 | Cellular component | Golgi lumen |
GO_0070062 | Cellular component | extracellular exosome |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0140911 | Molecular function | pore-forming activity |
GO_0005515 | Molecular function | protein binding |
Gene name | DEFA1 |
Protein name | Neutrophil defensin 1 (Defensin, alpha 1) (HNP-1) (HP-1) (HP1) [Cleaved into: HP 1-56; Neutrophil defensin 2 (HNP-2) (HP-2) (HP2)] |
Synonyms | MRS; DEFA2 DEF1 DEFA1B |
Description | FUNCTION: Effector molecule of the innate immune system that acts via antibiotic-like properties against a broad array of infectious agents including bacteria, fungi, and viruses or by promoting the activation and maturation of some APCs . Interacts with the essential precursor of cell wall synthesis lipid II to inhibit bacterial cell wall synthesis . Inhibits adenovirus infection via inhibition of viral disassembly at the vertex region, thereby restricting the release of internal capsid protein pVI, which is required for endosomal membrane penetration during cell entry . In addition, interaction with adenovirus capsid leads to the redirection of viral particles to TLR4 thereby promoting a NLRP3-mediated inflammasome response and interleukin 1-beta (IL-1beta) release . Induces the production of proinflammatory cytokines including type I interferon (IFN) in plasmacytoid dendritic cells (pDCs) by triggering the degradation of NFKBIA and nuclear translocation of IRF1, both of which are required for activation of pDCs . . |
Accessions | ENST00000645146.2 ENST00000382692.3 ENST00000644528.1 P59665 ENST00000382689.8 |